186
Views
2
CrossRef citations to date
0
Altmetric
Open Peer Commentaries

Fairness in Manufacturing Cellular Therapies

, &
Pages 68-70 | Published online: 05 Apr 2018
 
This article refers to:
Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility

CONFLICTS OF INTEREST

Pilar Ossorio is on the ethics advisory board for Astellas Pharma U.S., Inc. She has received less than $3000 in consulting fees from Astellas each year for the past two years. To the best of her knowledge, Astellas has no active immunotherapy products on the market or in development. Astellas does have a regenerative medicine, cell therapy product in development in the US (described on the firm's website). Krishanu Saha is a member of the forum on Regenerative Medicine (NASEM) and the Center for Cell Manufacturing (CMaT, NSF). These organizations provided reimbursement for travel expenses for meetings related to immunotherapy manufacturing.

Additional information

Funding

KS was supported by the National Institutes of Health (R35GM119644), National Science Foundation (EEC-1648035), National Science Foundation (CBET-1350178).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 137.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.